Neil Gregory Almstead, CHIEF TECHNICAL Operations OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 910 shares at $44.36 ($40K) on 2023-01-11, disclosed to the SEC on 2023-01-12.
Seasonal sale ($40k) by CHIEF TECHNICAL Operations OFFICER — this insider has traded PTCT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.93 | 27 | $1K | 2.9% |
| 2 | $42.93 | 473 | $20K | 51.2% |
| 3 | $44.36 | 27 | $1K | 3.0% |
| 4 | $44.36 | 383 | $17K | 42.8% |
| Total | $43.57 avg | 910 | $40K | 100% |
| Filing → |
| PTCT | SELL | 2026-06-30 | $693K | — | Filing → |
| PTCT | SELL | 2026-06-26 | $2.3M | — | Filing → |
| PTCT | SELL | 2026-06-24 | $1.9M | — | Filing → |